Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring cost reported in the current year.

IndigoVision has said turnover for the year ended July 31st is not expected to be less than £30m, with sales growth in the second half year expected to exceed 10% putting full year sales around 5% ahead of the previous year. Margins have improved compared with the previous year and costs have been well controlled, the Internet video security firm said. Operating profits are expected to not be less than £2.6m, more than double last year's total.

Silence Therapeutics said just under half of the shares it made available via open offer were taken up, raising £5.45m for the company.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

Provexis, a business that develops, licenses and markets scientifically-proven functional food and sports nutrition technologies, nearly doubled it losses to £4.3m (2011: £2.3m) despite posting soaring revenues for the year ended March 31st at £3.48m (2011: £0.05m). The firm was hit by amortisation and impairment charges totalling £1.39m and burgeoning administrative costs of £5.3m (2011: £1.3m). Basic losses per share were 0.28p compared to 0.17p the previous year. Cash at the end of the year fell from £7.55m to £1.45m year-on-year.

HaiKe Chemical Group, a petrochemical, speciality chemical and biochemical business, has reported slight turnover growth in the first half compared to the same period the previous year, mainly driven by a price increase in the refinery division, which itself made a gross profit, but a net loss. Both speciality and salt chemicals recorded volume increases, however prices have fallen as a result of a sluggish domestic economy. The group gross margin fell from 4.6% to 1.1% year-on-year. "Our main priorities will be to generate further cost savings and stabilise our earnings by streamlining our operations and improving internal synergies," the firm said.

NR